Celltrion
068270 · KRX · Health Care · Biotechnology and Biosimilars
公司简介
Celltrion is a South Korean biopharmaceutical company that develops, manufactures, and commercializes biosimilar medicines targeting major autoimmune and oncology conditions. It is one of the largest biosimilar producers globally and sells its products in the United States, Europe, and Asia through its commercialization subsidiary Celltrion Healthcare. The company operates large-scale mammalian cell culture manufacturing facilities in Incheon.
| 交易所 | KRX |
| 股票代码 | 068270 |
| 行业 | Health Care · Biotechnology and Biosimilars |
| 参考市值 美元 | $38.00B |
| 网站 | 访问官网 |
实时报价
正在加载实时价格……
| 市值 | |
| 当日区间 | |
| 52周区间 |
购买渠道
在其本地市场（KRX），可通过以下提供该交易所准入的全球券商进行投资：
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Korea Exchange, which operates the KOSPI Market for large-cap equities, the KOSDAQ Market for growth and technology companies, and a Derivatives Market division. — 官方交易所上市信息
仅为准入信息参考，不构成推荐或购买要约。请向您的券商确认资格、费用及当前可用性。
South Korea的其他公司
Samsung Electronics$970.50BSK Hynix$585.80BHyundai Motor Company$95.40BLG Energy Solution$76.80BSK Square$64.40BDoosan Enerbility$50.20BHanwha Aerospace$49.40BSamsung Biologics$49.00BKia Corporation$43.50BSamsung Electro-Mechanics$42.80BKB Financial Group$35.00BShinhan Financial Group$30.00BHana Financial Group$25.00BPOSCO Holdings$23.00BNaver Corporation$22.00BLG Chem$21.00BSamsung C&T Corporation$18.50BSamsung Life Insurance$18.00BSamsung Fire and Marine Insurance$16.00BSK Telecom$15.50BKakaoBank$14.00BKakao$13.50BLG Electronics$13.00BWoori Financial Group$12.00BSamsung SDI$11.50BSK Inc.$11.00BKrafton$10.50BKorea Zinc$10.00BHD Hyundai Heavy Industries$9.50B
公司数据及任何实时价格均为参考性质，可能存在延迟或不准确，仅供研究参考，不构成投资建议。请以交易所、公司公告及您的券商信息为准。